For years, time-restricted eating has been studied as a way to improve blood sugar in type 2 diabetes, but people with type 1 diabetes were usually left out. The reason was safety. When insulin must be dosed by hand, any change in meal timing raises a natural question: will a narrower eating window increase the risk of low blood sugar? A new study, the first randomised trial of its kind in adults with type 1 diabetes, set out to answer that question directly, and its results are encouraging enough to take seriously, without overstating what a small trial can prove.
The study compared three eating patterns over 12 weeks. All participants continued to use their usual insulin therapy, and none were asked to change the amount or type of food they ate. The only variable was when food could be eaten. That design matters. If the trial had also changed calories, diet quality, or insulin doses, it would be hard to know whether any benefit came from the timing itself or from something else.
What the study found, at a glance
- Time-restricted eating lowered HbA1c more than the other two eating patterns over 12 weeks.
- Participants spent slightly more time in their target glucose range.
- There was no increase in severe hypoglycaemia or other serious adverse events.
- Time-restricted eating also led to a small reduction in body weight.
- The trial was small, and the authors call for larger, longer studies.
Why type 1 diabetes was left out of the eating-window research
Type 1 diabetes is different from type 2 diabetes in one fundamental way: the body produces little or no insulin of its own, so insulin must be supplied from outside. That makes meal timing inseparable from insulin timing. If you eat later than planned, or skip a meal, the insulin already taken can act without food to balance it, and blood sugar can fall. That risk is why researchers were cautious about testing time-restricted eating in this group, even as trials in type 2 diabetes and in people without diabetes produced promising results.
The new trial addressed that concern head-on. Participants were adults with type 1 diabetes who were already using continuous glucose monitors (CGMs), which track blood sugar throughout the day and night. Continuous monitoring matters here, because it gives both participants and researchers a detailed picture of what happens between meals, including overnight, when a low can be hardest to notice. The trial also set clear safety rules: participants were told to break the fast and treat a low if their glucose fell below a set threshold, and the study team monitored adverse events throughout.
That context helps explain why the safety result is as important as the blood sugar result. A diet pattern that improves HbA1c but increases severe lows would be a poor trade. A pattern that improves HbA1c without increasing severe lows is a different proposition, and that is what this trial found.
The three groups, side by side
The trial was small but well structured. Seventy-eight adults with type 1 diabetes were randomly assigned to one of three groups for 12 weeks. The table below summarises what each group was asked to do.
| Group | What participants were asked to do | Who it included |
|---|---|---|
| Time-restricted eating | Eat only within a self-selected 8 to 10 hour window each day | Adults with type 1 diabetes, all using CGMs |
| Calorie restriction | Reduce daily energy intake by 25 per cent, without a set eating window | Adults with type 1 diabetes, all using CGMs |
| Usual care | Continue their normal eating pattern and insulin therapy | Adults with type 1 diabetes, all using CGMs |
Randomisation is important here. Because participants were assigned to groups by chance, rather than choosing the pattern they preferred, the groups started out similar in age, diabetes duration, and baseline HbA1c. That makes it more likely that any difference at the end of the trial came from the eating pattern itself, rather than from the kind of person who chose it.
On average, the eating window lasted 8 to 10 hours. That range matters, because it matches what most people describe as a practical daytime window, not an extreme fast. Each group’s window and duration stayed consistent over the study, which helps explain why the comparison was clean.
What changed, and what did not
The headline result was HbA1c, the standard measure of average blood sugar over about three months. The time-restricted eating group saw a greater reduction in HbA1c than the other two groups, with the largest difference compared with usual care. The calorie restriction group also improved, but not by as much. That ordering is worth noting, because it suggests that when food is eaten may matter at least as much as how much is eaten, at least over 12 weeks.
Time in range — the proportion of time spent with glucose between 70 and 180 mg/dL — also improved slightly in the time-restricted eating group. The change was modest, but it points in the same direction as the HbA1c result. A small gain in time in range, sustained over months, can mean fewer hours spent high or low, which is the day-to-day reality behind the average.
What did not change is equally informative. There was no increase in severe hypoglycaemia, defined as a low requiring assistance from another person, and no increase in diabetic ketoacidosis, a dangerous complication that can occur when insulin is insufficient. There were also no serious adverse events attributed to the eating pattern. For a first trial in this population, that safety profile is the finding that makes further research possible.
Weight also fell slightly in the time-restricted eating group, by an average of about 2 per cent of body weight. That is a modest change, and the authors do not present it as a weight-loss intervention. It is, however, consistent with the idea that a narrower eating window can reduce total intake without a formal calorie target, perhaps by cutting out late-night snacks or unplanned eating.
Where energy needs fit into the picture
Any eating pattern that changes when food is consumed also changes when energy is available, and that matters for people who need to match insulin to food. Readers who want to understand their own energy baseline can use a TDEE calculator to estimate total daily energy expenditure, which gives a starting point for thinking about how much food the body needs over a full day, before any timing pattern is layered on top. The study itself did not ask participants to hit a specific energy target, but knowing your baseline helps explain why a narrower window does not automatically mean under-eating, if meals within the window are adequate.
For people with type 1 diabetes, the practical link is insulin. A meal eaten within a window still needs the same careful insulin dosing as a meal eaten at any other time, and a missed meal still needs a plan. The study’s safety rules — break the fast for a low, monitor continuously, and seek help if needed — are a reminder that timing is a tool, not a replacement for the fundamentals of diabetes management.
That distinction is also why the trial’s design is useful for future research. By keeping food amount and insulin therapy constant across groups, the researchers isolated timing as the variable. Future trials can now build on that by testing different window lengths, different times of day, and longer durations, knowing that a basic 8 to 10 hour window did not raise safety alarms in this group.
The limits, stated plainly
Every trial has limits, and this one is no exception. The sample was small, with only 78 participants, and the duration was short, at 12 weeks. That means the study can show a short-term effect, but it cannot show whether the benefit lasts, whether adherence fades over time, or whether rare safety events would appear in a larger group. The authors are explicit about this, and they call for larger, longer trials before time-restricted eating can be recommended as standard care for type 1 diabetes.
The participants were also a selected group. All were using continuous glucose monitors, which is not yet universal, and all were willing and able to follow a structured eating pattern for three months. People without CGMs, people with a history of severe hypoglycaemia, and people with eating disorders were not represented in the same way, and the results should not be generalised to them without further evidence.
Finally, the effect sizes were small. The study showed a modest HbA1c improvement, a modest weight change, and a modest time-in-range improvement, but it did not show a transformation. Modest, in this context, is not a criticism. It is a reason to keep expectations proportionate while larger and longer studies are done.
What readers should take from this study
If you have type 1 diabetes, the sensible takeaway is not to start a new eating pattern on the basis of one small trial. It is to know that a carefully monitored, 8 to 10 hour eating window did not raise safety alarms in this study, and that it produced a small improvement in blood sugar compared with usual care and with calorie restriction alone. That is a reason for interest, and for conversation with your diabetes team, not for self-experimentation.
If you do discuss time-restricted eating with a clinician, the questions to ask are practical: what window fits your insulin regimen, how will you handle a low that occurs outside the window, and how will you monitor for patterns over weeks rather than days? The study’s safety rules provide a starting point for that conversation, but they are not a substitute for personalised advice.
For researchers, the trial opens a door that had been closed by caution. Time-restricted eating can now be studied in type 1 diabetes with a clearer sense of what is safe to test, and with a design that isolates timing from other variables. The next trials will need to be larger, longer, and more diverse, but they will not be starting from zero.
Frequently asked questions
What is time-restricted eating?
Time-restricted eating is a form of intermittent fasting in which all food is eaten within a set window each day, typically 8 to 10 hours, with no calories consumed outside that window. Water and other non-caloric drinks are usually allowed at any time. It does not, on its own, set a calorie target or restrict particular foods.
Did the study show that time-restricted eating is safe for type 1 diabetes?
Within the limits of a small, 12-week trial, yes. There was no increase in severe hypoglycaemia or diabetic ketoacidosis, and no serious adverse events were attributed to the eating pattern. That does not prove safety for everyone, and larger trials are needed, but it is a reassuring first result.
How much did blood sugar improve?
HbA1c fell more in the time-restricted eating group than in the calorie restriction and usual care groups, and time in range improved slightly. The changes were modest, not dramatic, and the authors present them as a promising signal rather than a proven treatment.
Should people with type 1 diabetes try time-restricted eating now?
Not without discussing it with their diabetes team. The trial was small and short, participants used continuous glucose monitors, and insulin dosing still needs careful management around any change in meal timing. The study supports further research and informed discussion, not self-experimentation.
What happens next in the research?
The authors call for larger, longer trials that test different window lengths and times of day, include a more diverse group of participants, and track adherence and safety over a longer period. Those trials will determine whether the modest benefit seen here holds up at scale.
What to watch next
The next step is not another small trial, but a larger one. Researchers will be watching for whether the HbA1c benefit persists beyond 12 weeks, whether adherence to an 8 to 10 hour window holds up in everyday life, and whether the safety profile remains clean in a more diverse population, including people without continuous glucose monitors.
For readers, the practical watchpoint is simpler. If time-restricted eating enters clinical guidance for type 1 diabetes, it will be because larger trials confirm both benefit and safety, and because clinicians have clear protocols for insulin adjustment, low management, and monitoring. Until then, the study is best read as a first, careful step: a pattern long studied in other groups has now been tested, cautiously and safely, in type 1 diabetes, and the results justify the next step, not a leap.
